[HTML][HTML] Is alpha-synuclein loss-of-function a contributor to parkinsonian pathology? Evidence from non-human primates

TJ Collier, DE Redmond Jr, K Steece-Collier… - Frontiers in …, 2016 - frontiersin.org
TJ Collier, DE Redmond Jr, K Steece-Collier, JW Lipton, FP Manfredsson
Frontiers in neuroscience, 2016frontiersin.org
Accumulation of alpha-synuclein (α-syn) in Lewy bodies and neurites of midbrain dopamine
neurons is diagnostic for Parkinson's disease (PD), leading to the proposal that PD is a toxic
gain-of-function synucleinopathy. Here we discuss the alternative viewpoint that α-syn
displacement from synapses by misfolding and aggregation results in a toxic loss-of-
function. In support of this hypothesis we provide evidence from our pilot study
demonstrating that knockdown of endogenous α-syn in dopamine neurons of non-human …
Accumulation of alpha-synuclein (α-syn) in Lewy bodies and neurites of midbrain dopamine neurons is diagnostic for Parkinson's disease (PD), leading to the proposal that PD is a toxic gain-of-function synucleinopathy. Here we discuss the alternative viewpoint that α-syn displacement from synapses by misfolding and aggregation results in a toxic loss-of-function. In support of this hypothesis we provide evidence from our pilot study demonstrating that knockdown of endogenous α-syn in dopamine neurons of non-human primates reproduces the pattern of nigrostriatal degeneration characteristic of PD.
Frontiers